Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of cariprazine in bipolar I depression: A double‐blind, placebo‐controlled phase 3 study

Published:2019-11-06 Issue:4 Volume:22 Page:372-384
ISSN:1398-5647
Container-title:Bipolar Disorders
language:en
Short-container-title:Bipolar Disord

Author:

Earley Willie R.¹,Burgess Maria V.¹,Khan Barbara¹,Rekeda Ludmyla²,Suppes Trisha³,Tohen Mauricio⁴^ORCID,Calabrese Joseph R.⁵

Affiliation:

1. Department of Clinical Development Allergan plc Madison NJ USA

2. Department of Biostatistics Allergan plc Madison NJ USA

3. Department of Psychiatry and Behavioral Sciences Stanford University School of Medicine and V.A. Palo Alto Health Care System Palo Alto CA USA

4. Department of Psychiatry and Behavioral Sciences University of New Mexico Albuquerque NM USA

5. Department of Psychiatry Case Western Reserve School of Medicine Cleveland OH USA

Funder

Allergan

Publisher

Wiley

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bdi.12852

Reference53 articles.

1. Psychosocial Disability in the Course of Bipolar I and II Disorders

2. The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder

3. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials

4. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder

5. Suicidality in bipolar compared to unipolar depressed inpatients

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data;Journal of Affective Disorders;2024-12

2. Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials;Journal of Affective Disorders;2024-10

3. Cariprazine in the acute treatment of unipolar and bipolar depression: A systematic review and meta-analysis;Journal of Affective Disorders;2024-10

4. Clinical challenges in the dosing and titration of cariprazine;Frontiers in Psychiatry;2024-08-30

5. Eficacia, seguridad y tolerabilidad de cariprazina en el trastorno depresivo mayor: Una revisión sistemática y aspectos prácticos;Psiquiatría Biológica;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3